Dendreon

Develops and manufactures personalized cellular immunotherapy for cancer patients.

BiotechnologyPharmaceuticals dendreon.com ↗

Company facts

Founded
1992
Employees
710
Headquarters
United States
Type
Private
Funding
Debt Financing · $10M · 2020